Xue-qi Liu
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Blocking ATP-P1Rs axis attenuate alcohol-related liver fibrosis.
Journal: Life sciences
Published: April 18, 2023
Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 16, 2023
CD73 aggravates alcohol-related liver fibrosis by promoting autophagy mediated activation of hepatic stellate cells through AMPK/AKT/mTOR signaling pathway.
Journal: International immunopharmacology
Published: July 06, 2022
Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease.
Journal: Frontiers in pharmacology
Published: June 11, 2022
Clinical Significance of Glomerular Autophagy in Evaluation of Diabetic Kidney Disease Progression.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 25, 2022
Identification of Genes Reveals the Mechanism of Cell Ferroptosis in Diabetic Nephropathy.
Journal: Frontiers in physiology
Published: March 06, 2022
Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation.
Journal: Kidney international
Published: January 18, 2022
Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis-Mediated Ferroptosis.
Journal: Oxidative medicine and cellular longevity
Published: December 10, 2021
Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.
Journal: Drug design, development and therapy
Published: March 12, 2021
Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Journal: Acta pharmacologica Sinica
Published: January 31, 2021
Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
Journal: Clinical science (London, England : 1979)
Published: September 25, 2020
Last Updated: 09/26/2026